Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anika Bergmann

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|December 4, 2018
[Exceeding the concentration]Anika Bergmann
Bone Marrow Transplantation|September 3, 2020
Wilm's Tumor 1-guided preemptive treatment with hypomethylating agents for molecular relapse of AML and MDS after allogeneic transplantationChristina Rautenberg, Anika Bergmann, Sabrina Pechtel, et al.
Cancers|August 19, 2020
Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell TransplantationChristina Rautenberg, Anika Bergmann, Ulrich Germing, et al.
Cancers|December 23, 2022
Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic ComponentVictoria Platte, Anika Bergmann, Barbara Hildebrandt, et al.
Therapeutic Advances in Hematology|June 24, 2022
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donorsCarmine Liberatore, Maria Teresa Lupo Stanghellini, Francesca Lorentino, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|December 4, 2018
[Exceeding the concentration]Anika Bergmann
Bone Marrow Transplantation|September 3, 2020
Wilm's Tumor 1-guided preemptive treatment with hypomethylating agents for molecular relapse of AML and MDS after allogeneic transplantationChristina Rautenberg, Anika Bergmann, Sabrina Pechtel, et al.
Cancers|August 19, 2020
Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell TransplantationChristina Rautenberg, Anika Bergmann, Ulrich Germing, et al.
Cancers|December 23, 2022
Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic ComponentVictoria Platte, Anika Bergmann, Barbara Hildebrandt, et al.
Therapeutic Advances in Hematology|June 24, 2022
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donorsCarmine Liberatore, Maria Teresa Lupo Stanghellini, Francesca Lorentino, et al.
Pageof 1